Another company has issued a recall for blood pressure medication that may contain chemicals known to cause cancer.
Aurobindo Pharma USA, Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets USP, Valsartan HCTZ Tablets, USP and Valsartan Tablets USP, according to the Food and Drug Administration (FDA).
The impurity detected in the finished drug product is N-nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification.
RELATED: More blood pressure meds recalled due to cancer-causing chemicals
To date, Aurobindo Pharma USA, Inc. has not received any reports of adverse events related to this recall.
These tablets are used to control high blood pressure and for the treatment of heart failure. Patients who have been prescribed these medications should continue taking them, as the risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment. Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication.
The products subject to recall are listed on the FDA’s website. The product can be identified by checking the product name, manufacturer details and batch or lot number on the bottle containing these products.